Management
CEO Mai-Britt Zocca
Ms. Zocca is the company’s chief executive officer. She holds a Ph.D. in immunology and a Master Sc. in Biochemistry. Her Ph. D. work is performed at the Institute of Medical Microbiology and Immunology, University of Copenhagen and at the National Cancer Institute (NIH), Bethesda, Maryland, USA. Prior to joining DanDrit Biotech A/S she was a Senior Researcher at the Department of Oncology, Herlev University Hospital.
CFO Dina Rosenberg Asmussen
Ms. Dina R. Asmussen is DanDrit Biotech’s former chief executive officer. She holds a Master Sc. Economics from Copenhagen Business School. She has many years of experience working with investments in biotech companies and running a biotech fund for Danske Bank.
Head of R&D Ayako Wakatsuki Pedersen
Ayako Wakatsuki Pedersen joined DanDrit Biotech A/S in May 2006. She completed her PhD in immunology at University College London (UK), then post-doctoral study at Duke University (NC, USA) where she studied differential activation of dendritic cells and therapeutic application of dendritic cells in murine cancer models.